je.st
news
Tag: primary
Saft lands contracts for 45M primary Li-ion batteries for smart meters in China
2015-11-03 15:55:29| Green Car Congress
Raytheon Completes Development of 3rd Generation Bradley Commander's Primary Sight
2015-10-15 12:31:10| Industrial Newsroom - All News for Today
Anticipating US Army proposal, upgraded to include dual-band thermal imager, hi-def camera TUCSON, Ariz. - Raytheon Company's (NYSE: RTN) Missile Systems business has completed the development of its 3rd Generation Commander's Primary Sight ahead of the U.S. Army's anticipated Improved FLIR lethality engineering...
Tags: development
primary
generation
3rd
For Rubio, Lack Of Time In N.H. Doesn't Seem To Be Hurting Primary Chances
2015-10-08 18:15:37| Oil & Gas - Topix.net
On an earlier visit to the state, Rubio held an event in Hollis. Over the summer, however, the candidate didn't make many trips to the state, which doesn't seem to be hurting him with voters Johnnie Koromilas has been an active Republican in her home city of Dover for decades.
Cabin Doors on the Airbus A350 are Lifting off with a Primary Structural Component Made from Victrex Peek Polymer
2015-10-06 12:31:12| Industrial Newsroom - All News for Today
WEST CONSHOHOCKEN, PA USA Airbus Helicopters is replacing aluminum in a fitting in the aircraft door of the Airbus A350-900 with a high-modulus, carbon fiber-reinforced high performance polymer. The brackets, now manufactured from VICTREX PEEK 90HMF40, has been developed by Airbus Helicopters and is in serial...
Tags: made
primary
component
doors
Pivotal Phase 3 Studies of Bezlotoxumab, Mercks Investigational Antitoxin to Prevent Clostridium Difficile Infection Recurrence, Met Primary Endpoint
2015-09-20 18:30:00| Merck.com - Research & Development News
Dateline City: KENILWORTH, N.J. Company Plans to Submit New Drug Applications in U.S., EU and Canada in 2015 Results Presented for the First Time at ICAAC/ICC 2015 Annual Meeting KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced that the two pivotal Phase 3 clinical studies for bezlotoxumab, its investigational antitoxin for prevention of Clostridium difficile (C. difficile) infection recurrence, met their primary efficacy endpoint: the reduction in C. difficile recurrence through week 12 compared to placebo, when used in conjunction with standard of care antibiotics for the treatment of C. difficile. Language: English Contact: MerckMedia Contacts:Doris Li, 908-246-5701Ian McConnell, 973-901-5722orInvestor Contacts:Teri Loxam, 908-740-1986Justin Holko, 908-740-1879 Ticker Slug: Ticker: MRK Exchange: NYSE read more
Tags: met
primary
studies
prevent
Sites : [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] next »